Nicotinamide partially reverses the interleukin-1β inhibition of glucose-induced insulin release in pancreatic islets
Authors:
- 1 March 1992
- journal article
- Published by Elsevier in Metabolism
- Vol. 41 (3) , 296-300
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Oxygen free radical scavengers protect rat islet cells from damage by cytokinesDiabetologia, 1989
- Effect of nicotinamide treatment on the residual insulin secretion in Type 1 (insulin-dependent) diabetic patientsDiabetologia, 1989
- Studies on the Mechanisms Causing Inhibition of Insulin Secretion in Rat Pancreatic Islets Exposed to Human Interleukin-1β Indicate a Perturbation in the Mitochondrial Function*Endocrinology, 1989
- Defective Catabolism of D-Glucose and L-Glutamine in Mouse Pancreatic Islets Maintained in Culture after Streptozotocin Exposure*Endocrinology, 1988
- Culture of mouse pancreatic islets in different glucose concentrations modifies B cell sensitivity to streptozotocinDiabetologia, 1988
- Inhibitory Effects of Interleukin 1 on Insulin Secretion, Insulin Biosynthesis, and Oxidative Metabolism of Isolated Rat Pancreatic Islets*Endocrinology, 1987
- Affinity-purified human Interleukin I is cytotoxic to isolated islets of LangerhansDiabetologia, 1986
- Mechanisms of streptozotocin- and alloxan-induced damage in rat B cellsDiabetologia, 1984
- Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide–adenine dinucleotideBiochemical Journal, 1974
- Pyridine Nucleotide Depletion in Pancreatic Islets Associated with Streptozotocin-induced DiabetesDiabetes, 1972